Indicates ‘×’ concentration for individual antivascular endothelial growth factor (VEGF) drug
| Anti-VEGF drug | Clinical dose (×)/4 mL of vitreous (mg) | Volume per 4 mL of culture media (mL) |
|---|---|---|
| Ranibizumab | 0.5 | 0.05 |
| Bevacizumab | 1.25 | 0.05 |
| Aflibercept | 2 | 0.05 |
| Ziv-aflibercept | 2 | 0.08 |